Company: IXHL
Filing Date: 2025-10-27
Form Type: DEF 14A
Source: 0001213900-25-102654
Chunk: 15

Company: Incannex Healthcare Inc.
Filing Date: 2025-10-27
Form: DEF 14A
Chunk 15
---
 Clark holds a MS degree in Pharmacology from New York Medical College. The board of directors has concluded that Mr. Clark should serve as a director because of his extensive regulatory experience in the life sciences industry. Independence Our board of directors has reviewed the materiality of any relationship that each of our directors has with the Company, either directly or indirectly. Our board of directors has determined that Robert Clark, Peter Widdows and Dr. George Anastassov are “independent directors” as defined under the Rules of Nasdaq. Our board of directors determined that Robert Clark, Peter Widdows and Dr. George Anastassov, who are members of our audit committee and/or compensation committee, satisfy the independence standards for such committees established by the SEC and the Nasdaq Listing Rules, as applicable. Troy Valentine and Joel Latham are not independent under the applicable rules of the SEC and Nasdaq. Committees of our Board of Directors and Meetings Meeting Attendance.During the fiscal year ended June 30, 2025, there were three meetings of our board of directors, and the various committees of our board of directors met one time. No director attended fewer than 75% of the total number of meetings of our board of directors and of committees of our board of directors on which he served during the fiscal year ended June 30, 2025. Our board of directors has adopted a policy under which each member of our board of directors makes every effort to attend each annual meeting of stockholders, absent unusual circumstances. All of our directors attended our in-person 2024 Annual Meeting. 10 Audit Committee.Our audit committee met one time during the fiscal year ended June 30, 2025. This committee currently has three members, Peter Widdows (Chairperson), Robert Clark and Dr. George Anastassov. Our audit committee’s role and responsibilities are set forth in the audit committee’s written charter and include the authority to retain and terminate the services of our independent registered public accounting firm. In addition, the audit committee reviews annual financial statements, considers matters relating to accounting policy and internal controls and reviews the scope of annual audits. All members of the audit committee satisfy the current independence standards promulgated by the SEC and by Nasdaq, as such standards apply specifically to members of audit committees. Our board of directors has determined that Mr. Widdows is an “audit committee financial expert,” as the SEC has defined that term in Item 407 of Regulation S-K. Please also see the report of the audit committee set forth elsewhere in this proxy